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Abstract
The sympathetic nervous system (SNS) is the main control center for the
neurogenic regulation of blood pressure and is affected in fructose induced
hypertension. The brain is by far the greatest consuming and energy demanding
organ in the body which has the ability to metabolize and generate fructose but
with consequences. Diets high in salt and fructose enter the body and eventually
crosses the blood brain barrier where it exerts its effects on SNS signaling. The
aim of this thesis is to determine the connection between fructose and
hypertension along with the detrimental effects of fructose within the brain. Here
we test the hypothesis that a high salt combined with a high fructose diet
contributes to hypertension by increased cerebral spinal fluid (CSF) sodium
concentrations which alter key neuronal signaling mechanisms.

viii

1 Chapter 1: Introduction
1.1 Overview and Significance
The increased intake of fructose in diets and the subsequent rise in
hypertension are in a parallel escalation in today’s western society[1]. It has
been shown that fructose can provoke hypertension [1, 2], and that the
central nervous system (CNS), particularly the sympathetic nervous system
(SNS) exerts major regulatory control over blood pressure [3-5]. SNS
dysfunction is also suggested as a component of fructose-induced
hypertension. Fructose-induced hypertension is more prevalent in those who
have had diabetes and obesity, and this can eventually lead to a more serious
condition like cardiovascular diseases and an increased risk of mortality [6, 7].
According to the Center for Disease Control, cardiovascular disease killed
nearly 801,000 people in 2017 and it’s predicted to kill 836,546 people in
2018. Hypertension is the primary threat for cardiovascular disease, and in
2017 45.6% of US adults have hypertension per the American Heart
Association[8].
It is well-established that elevated high salt plus fructose intake is the
primary influence in essential hypertension and the onset of other metabolic
syndrome disorders. It has also been established that fructose alone is
responsible for alteration in brain genes [9, 10], synaptic plasticity, and can
contribute to CNS impairment [11]. The majority of humans on the western
diet with hypertension consume a larger quantity of salt and sugar. The more
1

salt and sugar one ingests the higher their blood pressure threshold will
become. The less salt and sugar one consumes then the lower their blood
pressure will be and this prevents risks for many future diseases. It is
obvious that there are many factors when considering increased blood
pressure. For example, added sugars increase the onset of obesity and bring
about metabolic syndrome. Lanaspa 2018 et al. demonstrated that a high
salt diet can activate the aldose reductase-fructose kinase pathway in both
the liver and brain in mice. This study indicated that high salt can lead to
endogenous fructose production and develop leptin resistance and
hyperphagia, which is the origin for obesity, insulin resistance, and even fatty
liver which are the hallmarks for metabolic syndrome. In addition, a combined
high salt and fructose diet has been known to contribute to the onset of
hypertension as well. Gordish K.L. and Beierwaltes W.H. 2017 have revealed
that rats who consume a 20% fructose diet plus a high salt (4% NaCl) diet are
predisposed to salt-sensitivity which leads to sodium retention, and increased
blood pressure [12]. Studies of a high salt diet combined with a sugar diet
(fructose) is much more realistic when comparing animal models to the
current human’s diet habits. However, the molecular mechanisms that links
salt and fructose to hypertension is poorly understood. The discovery of
innovative mechanisms whereby a high salt diet may stimulate fructose
uptake and may contribute to hypertension via neuronal apoptosis from the
byproduct of acetate may clarify novel objectives for future treatments.
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1.2 Blood Pressure Regulation, Hypertension and Mean Arterial
Blood Pressure
According to the American Heart Association blood pressure by definition
is “A pressure that the heart creates which allows the blood to move
throughout the network of blood vessels including veins, arteries and
capillaries[13].” Blood pressure variations can arise from many different
modifiable factors including diet, smoking, alcohol, stress, exercise and more.
However, it is possible that blood pressure can also be regulated by nonmodifiable factors such as genetics, age, ethnicity, and family history. These
blood pressure fluctuations, that our body experiences on a regular basis are
monitored and regulated by our organism’s homeostatic mechanisms. The
blood pressure homeostatic mechanisms are very well connected to each
other. All mechanisms for blood pressure regulation include, but are not
limited to: 1) the neuronal mechanisms of blood pressure regulation short
term control, 2) the cardiovascular center via short-term control, and 3) the
kidney’s hormone mechanisms for long term blood pressure control.
The CNS which contains the neuronal mechanism of short term blood
pressure control has been demonstrated to be the primary control center for
blood pressure regulation[5]. The CNS communicates with several organs in
the circulatory system throughout the autonomic nervous system (ANS). The
cardiovascular center can regulate blood pressure by managing cardiac
output via regulating blood vessel diameter by vasodilation or
vasoconstriction[5]. Although, vessel diameter can alter blood flow, blood
3

viscosity and the length of the blood vessel is also a major factor in
determining blood flow resistance. The cardiac center may also regulate
blood pressure by either stimulating sympathetic cardiac nerves to increase
contractility or heart rate or inhibiting cardiac output by transmission through
parasympathetic vagus nerves to decrease heart rate. Information about the
state of the body can be received through baroreceptor and chemoreceptors
by the cardiovascular center. Baroreceptors monitor arterial blood pressure
and are primarily located in the carotid artery and sinus or in the aortic arch
above the right atrium. Chemoreceptors are sensory neurons that monitor
the body’s oxygen and carbon dioxide levels located in the carotid bodies and
aortic bodies[5].

1.3 Metabolic Syndrome and hypertension
Fructose-induced hypertension is more prevalent in those who have
symptoms of metabolic syndrome [6, 7]. Therefore it is nearly impossible to
discuss fructose-induced hypertension without mentioning metabolic
syndrome. Metabolic syndrome is a cluster of cardiometabolic risk factors
which escalates the risk for multiple chronic diseases including cardiovascular
diseases, stroke, and type two diabetes [14]. The cluster of conditions that
typically coincide with each other in metabolic syndrome include:
hypertension, elevated blood sugar, excess body fat around the waist,
obesity, abnormal cholesterol (ie. Low amount of high density lipids) and high
triglyceride levels [14]. The metabolic syndrome has many etiological factors,
4

however, a central factor is a poor diet which consists of high amounts of
fructose and elevated salt intake. A poor diet and sedentary lifestyle is the
major attribution for the foundation of metabolic syndrome. Highcarbohydrates and saturated fats may also be linked to metabolic syndrome.
Therefore, there is no consensus of the direct cause of metabolic syndrome.
The popular way of describing the pathophysiology of metabolic syndrome
is by discussing insulin resistance, which is the defect in insulin action which
results in hyperinsulinaemia, which is needed to maintain normal glycemia.
Insulin resistance has become an issue through the means of abundant fatty
acids because the fatty acids released adipose tissue mass. Interestingly, we
know that fructose is a lipogenic sugar that is directly metabolized in the liver,
and either stays in the liver – contributing to a fatty liver—or transports directly
to the blood stream [15, 16]. When a high concentration of fructose enters
the blood it will directly be metabolized into fatty acids, triglycerides, lactate,
and glycogen. This will travel around the body’s vasculature until in either
accumulates in the blood vessel walls and/or into the cerebral spinal fluid or
makes its way into the brain via monocarboxylate shuttles resulting in an
increased in brain lactate and acetate (data not yet published). When a high
salt diet and high fructose diet is combined, the salt has the ability to stimulate
the fructose uptake acquiring a salt-sensitivity, retaining sodium in the blood
stream and creates an increase in blood pressure (demonstrated in rats) [12].
The high salt and fructose diet may be contributing to an insulin resistance
and therefore leading to hypertension or vice versa, however, detailed
5

mechanisms are still unknown. Still, insulin resistance and fatty acids
increase the production of glucose, triglycerides, and very low-density
lipoproteins (VLDLs), which is very similar to how the body reacts to a high
fructose corn syrup drink.

Hypertension has been described in a variety of

different ways with diverse proposed mechanisms. For example, since insulin
is a vasodilator, and has the ability to create sodium reabsorption in the
kidney, the vasodilator effects of insulin may become lost, and sodium
reabsorption is conserved [15, 16]. Fatty acids have the ability to mediate
vasoconstriction, which might be why vessels are damaged, and the side
effect is an increase in blood pressure. Also, hyperinsulinemia may be
related to an increase of sympathetic nervous system activity and ultimately
contributing to hypertension [15, 16].
Metabolic syndrome and its components are very intricate; however,
abdominal obesity appears to be an important contributing factor. In some
theories, it has been presumed that visceral adipose tissue creates a flux of
adipose tissue-derived fatty acids transferred to the liver from the splanchnic
circulation, which is expected [15, 16]. This tends to increase the
subcutaneous fat, releasing lipolysis into the systemic circulation instead of
utilizing direct hepatic metabolism, similar to when we eat a high fructose diet.
Although fructose is metabolized directly in the liver, the abundance is so
shocking to the liver that it pours into the blood stream resulting in an
increase in fatty acids contributing to visceral fats [15, 16]. Remarkably, the
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4% NaCl plus 20% fructose drinking water has been show to generate obesity
in Sprague Dawley rats in just three weeks (data not yet published).

1.4 The relationship between rats and humans and their diet
intake
The relationship between rats and humans can be contemplative in
science. Often times the rat model compared to the human is not explained
very well. In this thesis, this thesis will iterate why the comparisons between
a rat and human are performed.
The rat model is the preferred model of human cardiovascular and
neurosciences[17]. This is because the physiology of the rat is simple to
monitor, along with the fact that we have accumulated an enormous amount
of data[17]. It has been demonstrated that the rat model regarding physiology
is close to the human for examples, cognition is superior in the rat and the
rat’s neuro circuitry regarding memory and learning is quite comparable to the
human[17].
Interestingly a rat’s age can also be compared to the human age[18]. Per
Robert Quinn one human year is comparable to about 10 rat days for adult
rats which they’re considered to be adults when they reach sexual maturity
around 6 weeks[19]. In this thesis we have used 8-week-old rats which are 2
weeks past sexual maturity/adult hood but this is comparable to a ~18 year
old human[19] when you use the calculations that during the rat adult phase

7

11.8 rat days equals ~1 human year. The following flow chart below
demonstrates the outlined ages of the rats for this thesis.

Wait for
SD males
rats to
become 8weeks-old

Give
special
diet for 3
weeks

Metabolic
cages for
4 days

Take CSF,
blood, and
euthanize
rats
immediatly
for tests

In this thesis we have used 1 control diet and 3 special diets. The normal
salt (NS) or control group was fed 0.4% NaCl chow and normal drinking. The
high salt (HS) group was given a 4% NaCl diet with normal drinking water.
The fructose (F) group was given a normal salt chow with 20% fructose in
their drinking water. Finally, the high salt plus fructose (HS+F) rat group was
given a 4% NaCl chow plus 20% fructose in their drinking water. The water
was from the tap and then was autoclaved. The fructose was added after the
water was autoclaved. The fructose water bottles were changed every three
days to prevent any bacterial growth. The diagram below indicates the
approximate value of water and food intake per each day for each group
(from my metabolic data, this is the averaged data for each day of
consumption, whole numbers will be used for simple mathematics). This will
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be further used to explain why how diet is comparable to humans. Data for
metabolic cages are in the results section of this thesis.

9

The approximate value of food intake for SD adult male rats after a three
weeks of a special diet treatment data from metabolic cage
measurements (rounded to the nearest whole number)
Rat

Norma

4%

20%

Norma

Calorie

Calorie

Total

Averag

Group

l Chow

NaCl

fructos

l water

s from

s from

calori

e body

Cho

e water

chow

fructos

e

weight

e water

intake

of rat

X

70

w
Control

22 g

X

X

25 mL

70 Kcal

(NS)

377 g

Kcal

High

X

23 g

X

45 mL

71 Kcal

X

Salt (HS)
Fructos

71

376 g

Kcal
15 g

X

19 mL

X

48 Kcal

76 Kcal

e (F)

124

364 g

kCal

High

X

13 g

34 mL

X

40 Kcal

Salt and

136

176

Kcal

kCal

355 g

Fructos
e (HS+F)

Based off the following custom diet from Envigo:
•
•
•

4.0% NaCl= 3.1 Kcal/g Envigo TD.92034
0.4% NaCl=3.2 Kcal/g Envigo TD.96208
1 gram of fructose is equal to 4 Kcal/g

In the above table the relationship between kilocalorie (Kcal) and fructose
consumption was made. Body weights were given for reference. Sprague
10

Dawley (SD) rats are comparable to healthy humans without any diseases or
health issues. For the control diet (NS, normal salt diet, 0.04%), this would be
relative to a healthy human diet. Including vegetables, protein, minimal
carbohydrates, and no processed sugars while only drinking water. The high
salt (HS) diet is comparable to a human diet who consumes 4% salt or the
equivalence of 120,000 mg of NaCl with normal drinking water per day, no
sugary drinks. The 20% fructose diet (F) would be comparative to a human
diet who drank 500 calories of fructose sugary drink, whose total calorie
consumption is based on a total of 2500 calories per day. Finally, a high salt
and fructose diet would consist of a human to eat a combination of about
120,000 mg of NaCl plus drink 500 calories of fructose per day based on a
calorie diet of 2500 calories/day.
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2 Chapter 2: Fructose Effects on the Central Nervous
System; Review Article
2.1 Abstract
Fructose has detrimental effects on human physiology, and has been
linked to obesity, cardiovascular diseases, and hypertension. However, the link
between fructose-induced hypertension within the central nervous system (CNS)
is poorly understood. The objective of this paper is to shed light on the research
linking the contribution of fructose to CNS control of blood pressure. This paper
aims to elucidate the connection of fructose to inflammation, and fructose leads
to the elevation of lactate in the CNS which ultimately contributes to
hypertension. A comprehensive overview of metabolism of fructose within the
body and CNS are discussed. The by-product of reactive oxygen species (ROS)
and nitric oxide (NO) from fructose feeding within areas of the brain are
discussed as well. This paper discusses the issue that fructose has devastating
effects on astroglial, neuronal, and microglial cells. Furthermore, the molecular
mechanisms of fructose induced inflammation that regulate histone
deacetylases3 (HDAC3) - toll-like receptor 4/ nuclear factor-kB (TLR4/NF-KB)
pathway is discussed as one of the main molecular pathways in which
hypertension is induced in the paraventricular nucleus (PVN). Finally, this paper
brings to light that fructose and salt are synergistically interconnected in the
intestine and kidneys shown by glucose transporters and sodium hydrogen
exchanger (NEH3) expression.
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2.2 Introduction
The limitless escalation of fructose in today’s western world diet is
worrisome because it is related with a parallel increase of obesity[20, 21],
hypertension[22], and cardiovascular diseases[23]. Fructose is incorporated into
our foods by a more common additive known as high fructose corn syrup
(HFCS), which is a high level processed sugar including at least one genetically
modified organism (GMO)[21]. Specifically, fructose is a glucose sweetener used
as an alternative for sucrose and can be found in pops, condiments, juices,
baked goods, and candies[24]. Although a lot of the population has started to
recognize that HFCS is linked to weight gain, hypertension, and cardiovascular
disease some brand name products have renamed “high fructose corn syrup” on
their food labels to “natural sugars” to trick buyers into consuming their products
and making unhealthy decisions[25].
Fructose is a ketonic monosaccharide consisting of a five-member ring
structure with the same molecular formula of glucose (C6H12O6), which instead is
a five-member ring structure and an aldehyde[24]. Fructose is commonly derived
from sugar beets or sugar canes and is present in small amount of fruits and
honey[24]. It is well known where we can get fructose or HFCS, but the detailed
metabolism and transportation of fructose around the body seems to be a greater
mystery.
Fructose is transported passively via facilitated diffusion by a glucose
transporter called GLUT5 [26-28]. GLUT5, a uniporter, is special in the way that
13

is can solitarily transport fructose and does not have the capability to transport
glucose or galactose.[26, 28, 29]. GLUT5 is highly expressed in the small
intestine while there are minimal quantities of GLUT5 expressed in the brain,
adipose tissues, sperm, skeletal muscles, and kidneys. Interestingly, the chronic
ingestion of the GLUT5 substrate fructose has been linked to disorders like type
two diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD),
inflammation, and obesity[28, 30].
GLUT5 is only capable of transporting fructose but another glucose
transporter, GLUT2, is the only other glucose transporter which can also transfer
fructose but with a caveat [31]. The caveat is that GLUT2 does not solely
transport fructose, it has the ability to convey glucose and galactose as well [31].
GLUT2 is also a facilitative glucose transporter and has been discovered to be
located in the pancreatic beta-cells, liver, intestinal mucosa, kidneys, and in the
hypothalamus area [31, 32]. It seems that between GLUT2 and GLUT5
expression, GLUT5 may have a larger connection to inducing hypertension
rather than any other GLUT.
Many clinical studies have been leaning toward the role of the CNS as one of the
main connections contributing to the onset of fructose-induced hypertension [3,
33] However, the connotation among salt stimulated fructose inducedhypertension is still lacking in definition because current studies have contributed
very little to these findings. A common fructose-induced hypertension study was
done by Farah V. and researchers who have demonstrated that a fructose diet
14

increases mean arterial pressure (MAP) and disrupts insulin homeostasis of male
Wistar rats when fed a 66% fructose diet over ten weeks [34]. To shed light on
salt stimulated fructose-induced hypertension, Gordish et al. 2017,
demonstrated that systolic blood pressure was increased when salt (4% NaCl
chow) was added to the 20% fructose water diet in Sprague Dawley (SD) rats
compared to the control, fructose alone, and salt alone [35].
This review will aim to focus on the role of fructose and its effects on the
central nervous system, by evidence of several fructose feeding animal studies.
Since fructose is transported by GLUT5, the expression of GLUT5 in the brain
and spinal cord will be assessed. The effects and actions of fructose on the CNS
lead to increase in food intake will also be discussed. A comprehensive
evaluation of fructose metabolism in the body and brain will also be discussed.

2.3 The pathway of fructose metabolism
Fructose-1-phosphate pathway, and fructose-6-pathway are two of the
passageways that fructose is metabolized. Fructose 1-phosphate pathway
requires ketohexokinase/fructokinase, an enzyme that catalyzes the transfer of a
phosphate group from ATP to fructose. The results of fructose 1-pathway by the
enzyme fructosekinase traps fructose’s metabolism in the liver. The fructose 6phosphate pathway is an intermediate of glycolysis and gluconeogenesis.
However, the fructose-6-phosphate pathway has a low affinity for fructose and a
high Km value which is unfavorable. Km is the concentration of substrate in
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which the enzyme is able to reach half of the catalyst rate constant[36]. The
preferred pathway for fructose metabolism is the fructose-1-phophate pathway
which is located almost entirely in the liver.
Fructose is almost completely metabolized in the liver because of the
favored fructose-1-phosphate pathway due to the low Km value and high affinity
for fructose [26, 37]. One of the resulting products from fructose metabolism in
the liver is glycogen[38]. Liver glycogen is considered to be a fuel reserve and
can easily be broken down into glucose molecules when needed[38]. However,
HFCS can often cause the liver to be overwhelmed and that can create a huge
burden resulting in hepatic steatosis (fatty liver). When the liver is stunned with
excessive fructose then that fructose will become converted into free fatty acids
via de novo lipogenesis and stored as endogenous triglycerides or very lowdensity lipoproteins (VLDL)[26, 37, 39]. The storage of fatty acids, VLDL and
triglyceride are eventually stored as fat within the liver[39]. The metabolism
burden of fructose on the liver results in the increase of endoplasmic reticulum
(ER) stress and reactive oxidative species (ROS) production, known to stimulate
insulin resistance[39]. Fructose may also be metabolized in the intestine[29],
kidney, skeletal muscles, testes[29], and the brain.[39]. The metabolism of
fructose in the brain is further discussed in the next section.
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2.4 The metabolism of fructose in the brain
Fructose is not only metabolized in the liver or intestine, it is also
metabolized by other tissues including the brain which has been shown in
oxidative assays which measures oxidative stress of dissected brain regions from
adult mice [12, 18]. Sarah A. Oppelt et. al. and Funari V.A. et. al. discovered that
the cerebellum, hippocampus, cortex, and olfactory bulb of adult mouse brain
slices included a substantial number of neurons and glial cells comprised of
expressing genes for fructose-1-phosphate pathway cascades [12, 18, 20]. This
suggests that fructose may be metabolized in those brain areas [12, 18, 20].
Even in the hypothalamus, the brains metabolic control center, has been
recognized in fructose metabolism which contributes to alterations in gene
activity [17, 18].
The human body and brain both contain aldose reductases, and sorbitol
dehydrogenases which has the ability to reduce glucose to sorbitol and oxidize
sorbitol to fructose, respectively [40]. Sorbitol (C6H14O6) is a type of sugar
alcohol which was extracted from glucose and is commonly used as an
alternative sugar in foods[41]. This ultimately means that glucose can be
converted to sorbitol and then further oxidized to fructose. This is considered to
be the polyol pathway, an alternative glucose pathway [40].
For some reason the brain can bypass the rate-limiting step in glycolysis
but with consequences. This rate-limiting step results in the phosphorylation of
fructose-6-phosphate to form fructose-1,6-bisphosphate. The purpose is to
17

convert fructose directly to malonyl-CoA, which requires energy to elongate the
fatty acid chain[42]. The result is that the metabolism of fructose in the CNS
rapidly depletes hypothalamic adenosine triphosphate (ATP)[42]. The
exhaustion of ATP in the hypothalamus will then lead to the upsurge of
adenosine monophosphate (AMP) and initiation of adenosine monophosphate
kinase (AMPK) signaling, plus increase of food intake which can result in the
consequence of weight gain[42]. Interestingly, it is unclear whether fructose
crosses the blood-brain barrier but it’s known that fructose can be endogenously
produced from glucose to sorbitol and finally to fructose [19]. However,
according to researchers Janice J. Hwang et. al. from Yale University the polyol
pathway subsidizes fructose production in the CNS from glucose, which is
related to intracerebral fructose changes and is not correlated to the human
plasma fructose levels[43].

2.5 Fructose effects on the CNS
Overwhelming publications demonstrate that the CNS play a more
imperative role in the control of blood pressure and cardiovascular function than
was previously thought. The CNS is responsible for regulating the sympathetic
nerve activity (SNA) and blood pressure which directly contributes to dissimilar
types of hypertension [44]. In some way the CNS indirectly contributes to all
categories of hypertension but the mechanisms have remained
undistinguishable. Remarkably, the CNS is considered to be the main regulator
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for blood pressure control due to the sympathetic nervous system (SNS) which is
part of a larger system called the autonomic nervous system (ANS).

2.6 Fructose effects on obesity related hypertension
Melanocortin, a collection of peptide hormones derived from the proopiomelanocortin (POMC) in the pituitary gland, and its receptor activities in the
brain has been demonstrated to regulate blood pressure and the SNS activity in
humans and animal models [33, 45, 46]. POMC neurons tend to result in a
decrease of food consumption along with weight loss[47]. However, the
activation of neuropeptide Y and agouti-regulation protein (NPY-AGRP) neurons
consequence in weight gain and increased food consumption[47]. Melanocortin4 receptor (MC4R) has been known to play a role in body weight regulation,
feeding behavior, the regulation of metabolism, and blood pressure regulation
[46]. MC4R is the key mediator of the two neurons POMC and NPY-AGRP and
has an effect to determine which will be activated specifically in areas including,
but not limited to, the paraventricular nucleus (PVN)[47].
Obesity-related hypertension is highly linked to MC4R and has shown to
be MC4R dependent[48]. Animals with hypertension and an increased SNS
activity were given a blockade of MC4R which decreased blood pressure, heart
rate, and the SNS response. MC4R is important for the control of food because
it mediates NPY-AGRP and POMC neurons which is linked to the initiation of
signaling cascades involved with leptin receptors. Leptin is primarily involved in
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the regulation of food consumption. It is a hormone secreted from white adipose
cells that is associated with inhibiting the hunger sensation by acting on
receptors in the arcuate nucleus of the hypothalamus (ANH). Leptin intravenous
infusions have been found to increase blood pressure in rodents with severe
obesity[49]. The leptin obese rodents produced continuing increases in blood
pressure (6 mm Hg after 7 days), heart rate, and adrenergic activity[50]. Clinical
studies on hypertensive humans have shown that elevated plasma leptin has a
correlation between high levels of leptin which occurred in hypertensive patients
compared to non-obese normotensive patients [49, 51]. The CNS links the
MC4R-expressing neurons to the POMC and NPY-AGRP neurons by projections
in the area of the PVN. MC4R is located on the axon terminal of the PVN and
can increase the amount of gamma-amino butyric acid (GABA) that can be
released to the neurons of the PVN, and has a strong connection to obesityrelated hypertension [48]. When GABA, a neurotransmitter, is secreted from
NPY/AGRP neuronal axon terminals this will block the POMC neurons ultimately
resulting in weight gain and uncontrollable feeding[52]. The increasing levels of
leptin in obese hypertensive humans are in correlation to increased MCR4 in the
CNS [53, 54]. Obesity is linked with increased levels of MC4R which is known to
be related to increased activity of renal SNS and increased sodium absorption
which further associates it to induced hypertension[54].
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2.7 Fructose effects on the CNS contribute to hypertension
Fructose is vastly connected to obesity and hypertension in the today’s
western society [20, 55]. NPY itself is involved in enhanced food intake,
involved with obesity, and is the most abundant peptide in the CNS[53]. MC4Rexpressing neurons are involved in both hypertensive and obese rodents and
humans[54]. Fructose is consistently used in our daily processed foods and
although fructose is mainly metabolized in the liver, small amounts are
metabolized in the intestines and will contribute to enhance feeding due to
continuing MC4R expression of neuron in the NPY. Taken together these all
suggest that CNS plays a more critical role in the control of fructose-induced
hypertension [33, 45, 46].
The CNS play an imperative role on fructose-induced hypertension by the
involvement of neuronal nitric oxide synthase (nNOS) in the NTS, reactive
oxygen species (ROS) in the RVLM, and downregulating superoxide dismutase
SOD1 and SOD2.

2.8 The role of a high fructose diet on nitric oxide production
Nitric oxide is considered to be a radical gas, but it has an important role
in biological processes such that it is an important molecule in signaling
cascades. [56, 57]. There are three types of nitric oxide synthase which are
neuronal nitric oxide synthase (nNOS), endothelial nitric oxide synthase (eNOS),
and inducible nitric oxide synthase (iNOS)[56].
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NO in the blood vessel wall is produced via the cascade of the calciumcalmodulin scheme; endothelial nitric oxide synthase (eNOS) is critical for
preventing damage to the walls of vasculature[58, 59] Particularly, eNOS
dysfunctions have been linked to hypertension as well [58]. However, there are
other areas in your body such as in the CNS where nitric oxide plays a critical
role in synaptic plasticity, sleep-wake cycles, and the regulation of hormone
cycles [56, 58].
Within the CNS of a healthy individual, nNOS, reacts with any superoxides
(O2•-) that have accumulated from risk factors like fructose-induced hypertension
or glucose increases[56]. Following this reaction, nNOS and O2•- will then
combine together to form peroxynitrite, which reduces ROS scavenging
capabilities for the neuron cells [58]. When the body undergoes salt
consumption or obesity, sympathoexcitation occurs from oxidative stress in the
rostral ventrolateral medulla (RVLM). Fructose has been shown to stimulate
sympathetic over activity and excite the brain during fructose intake. However,
when adult normotensive rats were subjected to an 8 week diet of fructose
(increased risk factor), nNOS developed a vicious cycle and eventually
generated enzymes that produced superoxides[60]. The tissue of the rostral
ventrolateral medulla (RVLM) level of NO was shown to decrease and ROS
production increased simultaneously [60]. nNOS protein expression in the RVLM
was significantly increased after the 8 week diet of fructose intake of these
rats[60]. The superoxides that started to build up in the RVLM eventually
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resulted in free radicals and the consequence that of oxidative stress, leading to
fructose-induced hypertension and sympathoexcitation [60].
nNOS has been linked to hypertension due to that fact that nNOS is dominantly
contributed to the control of intracellular calcium homeostasis in the heart[57] and
in the CNS[61, 62]. Blood pressure is highly regulated by intracellular calcium
because an influx of calcium into vascular smooth muscles can result in an
intensified muscular morphology, tone, and increasing vascular resistance thus
resulting in elevated blood pressure[63, 64]. Cirello J et. al, 2012 has revealed
that a calcium regulating glycoprotein hormone stanniocalcin-1 has been
demonstrated in the nucleus solitary tract (NTS) was involved in the regulation of
neurons that participate in controlling arterial blood pressure via the baroreceptor
reflex[65]. It has been demonstrated that extracellular-signal-regulated kinase
(ERK) is involved in the regulation of blood pressure in the NTS[62]. With this
evidence, it is indicated that the CNS plays an important role in hypertension
from the contribution of nNOS and eNOS synthases.
Other studies have showed that microinjection of angiotensin I and
angiotensin II into the third cerebral ventricle of the brain considerably elevated
blood pressure compared to the administration of the drugs in the peripheral
blood of rats[66] and dogs[67]. These results further demonstrate that the
elevation of blood pressure originated from activating neuronal mechanisms
rather than peripheral vasoconstriction activities[66]. Specifically, it has been
demonstrated that brain angiotensin II is one of the notable contributors which
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links the CNS to reactive oxygen species-dependent hypertension (discussed
later) [67].

2.9 The role of a high fructose diet and ROS production
Interestingly, ROS is generated from neuron cells itself and is also
generated by microglial cells and astrocytes which can transform communication
to and from neurons by inducing long-term potentiation or modulating synaptic
plasticity [68]. We have mentioned above that GLUT5 is localized in microglial
cells and it’s capable of depleting ATP levels and increasing AMP levels in the
CNS [69]. However, during the depletion of ATP levels, fructose is eventually
metabolized to uric acid and uric acid has been found to stimulate ROS by the
activation transforming growth factor beta-1 and nicotinamide adenine
dinucleotide phosphate (NADPH)[70]. Fructose has also been linked to
intracellular phosphate depletion as well as a significant decrease in AMPK
phosphorylation. A rise in intracellular uric acid is proficient in producing
proinflammatory effects on the CNS, liver, and vascular cells. For example,
metabolizing fructose during a fructose load generates a surge in intracellular
uric acid levels, and with a continuous consumption of fructose intake signals
your body to produce fructose enzymes. The fructose enzymes allow your cells
to become sensitive which contributes to an overproduction of uric acid known as
hyperuricemia, triglycerides and free radicles[71]. Fructose, which produces uric
acid as a byproduct when metabolized, has been linked to metabolic diseases
particularly in connection with hypertension. The amplification in uric acid has
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been shown to decrease nitric oxide (NO) levels and is likely the incentive for
oxidative stress[71].
Keep in mind that the microglial cells are a specialized type of
macrophages within the CNS and contributes to an enormous part of the
inflammatory and immune responses of the CNS during fructose loading [41].
High levels of fructose contributes to elevated levels of intracellular uric acid
which can induce oxidative stress in the CNS, vascular cells and liver. When
oxidative stress is induced, the macrophages in the CNS produce a response via
signaling molecules. However, when reactive oxygen species (ROS) occurs
during fructose loading the cell’s oxidative damage results in intracellular DNA
damage, this sends out a stress response to release the pro-inflammatory
cytokines (PIC)[72]. The increase in oxidative stress and ROS are both
important pathogenic influences regarding hypertension development and
diagnosis [56]. ROS that is produced in the neuronal, vascular system, or renal
system is able to influence signaling molecules and can lead to hypertension
[56]. For example, when rats were fed 10% fructose for 4 weeks they formed
fructose induced hypertension and their ROS levels in the nucleus tractus solitarii
(NTS) tissue were significantly greater and the NO levels were significantly
reduced [2]. When ROS occurs during fructose loading the cell’s oxidative
damage results in intracellular DNA damage which sends out a stress response
to release pro-inflammatory cytokins (PICs)[72].
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2.10 The role of high fructose and antioxidant imbalance
When free radicles are formed in the body antioxidants can
inactivate/quench them. Superoxide dismutase 2 (SOD2) is an antioxidant
enzyme within the mitochondrial matrix that has the ability to destroy superoxide
anion radicles that are toxic to the neurons [2]. The mutation of SOD2 has even
been linked to neurodegenerative diseases like amyotrophic lateral sclerosis or
leigh syndrome[73]. SOD is usually the immediate defense against ROS
production and the decrease of SOD2 indicates that fructose feeding promotes
ROS imbalance [2]. SOD2 was demonstrated to be significantly down regulated
in the NTS of the fructose fed (10%) rats compared to the control while their
systolic blood pressure become elevated (~15mm Hg compared to control)[2].
Fructose feeding for 4 weeks in rats enhanced ROS production in the NTS and
that has been linked to neuropathogenesis of hypertension, neurodegenerative
diseases, and the pathophysiology or cardiovascular diseases [2]. There are
other sources of ROS that maybe linked to ROS-dependent hypertension; for
example NADPH oxidase (NOX) [66, 67].

2.11 Fructose and the blood brain barrier
In the CNS, cells are responsible for their own energy, metabolizing
glucose and lipids. However, the brain alone is one of the most energy
demanding organs in the human body because it is full of neurons that starve for
glucose. It is well known that glucose is the primary substrate needed for the
brain to carry out its functions and that glucose can cross the blood brain barrier
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by the help of glucose transporters. Although there seems to be a large debate
in regard to fructose - fructose can pass through blood brain barrier? This
section does not choose one side instead you will see the data behind both
ideas.
8 healthy women and men were given a 20% dextrose (sucrose and
fructose mixture) though a constant 4 hour intravenous injection to their arm, the
dextrose levels were held at the same concentration (220 mg/dl) for 4 hours long
[20]. Janice J. Hwang et. al. found that these participants had high levels of
intracerebral fructose levels by magnetic resonance spectroscopy (MRS)
scanning[43]. Furthermore, they discussed that the reason is due to the polyol
pathway which suggests that fructose is produced endogenously in the human
brain from the process of glucose to sorbitol to fructose [43]. In another study
from Janice, the fructose measurements within the cerebral spinal fluid were 20
times higher compared to the concentration of plasma fructose levels from
healthy and obese pregnant woman [40] suggesting that the polyol pathway is
involved in fructose endogenous CNS creation. In both studies Janice J. Hwang
et. al. suggested that fructose is generated from glucose in the human brain
during hyperglycemia[40][20]. Results from Janice J. Hwang et. al. experiment
indicated that glucose levels mediate fructose levels in the brain. In addition, any
increase in blood glucose contributed to fructose’s effects on the brain [20] . This
compelling evidence demonstrates that fructose may not pass through the blood
brain barrier rather fructose can be generated by the brain.
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Contradicting experiments indicate that fructose can enter the brain by a
presence of GLUT5 in the blood brain barrier in rats that consume a high fructose
diet [26]. Shu HJ et. al. has shown that brain cerebrum mRNA levels of GLUT5
increase 1.5-fold in male rats after only seven days of fructose feeding[26]. It is
suggested that fructose can be utilized as an alternative energy source in the
brain during a time of critical need [22, 26, 27]. With the provided data, fructose
was demonstrated to cross the blood brain barrier when fructose was given
though ingested (feeding) and given by an intraperitoneal injection [42, 74].

2.12 Fructose Causes Lactate Elevation Which May Contribute to
Hypertension
When 10 volunteers received a 10% intravenous (IV) dose of fructose at
0.5 grams per kilogram of body weight per hour for two hours it was found that
their serum lactate rose significantly during this fructose administration[75].
Interestingly, lactate is able to cross the blood brain barrier (BBB), and can easily
be taken up by the brain[76]. When lactate levels rise in the blood from IV
fructose[76], then we can assume that there is a net influx of lactate from the
blood into the brain. Elevated blood lactate levels have been linked to
hypertension especially in women[77]. In another study, blood lactate was
elevated twice as much in obese-hypertensive patients compared to their lactate
levels after weight loss[78]. It seems that lactate levels fluctuate with blood
pressure, when patients are hypertensive they had elevated lactate levels in their
blood[78]. Fructose given by IV was shown to increase blood lactate, with what
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we know lactate can cross the blood brain barrier[76], and can definitely
influence hypertension. Lactate is a product of anaerobic metabolism and is a
link between oxidative metabolism and glycolysis and furthermore after lactate is
formed, pyruvate can be converted to glucose in the gluconeogenesis
pathway[79]. It is known that muscles can generate lactate especially during
high intensity exercising, and also that the heart, liver and kidneys can use
lactate as fuel[79]. However, in the brain the role of lactate in sparing amounts
may be used in assistance to neuronal action potentials firing rates. When
lactate is in the brain in large quantities it may be linked to neurodegenerative
diseases and is not used as an energy source[79]. In the brain, lactates utilize
an astrocyte-neuron lactate shuttle which has been hypothesized that “astrocytes
metabolize glycogen and glucose to lactate which is transferred to neurons
through the axons juxta synaptic process according to Smith et al. 2003. [79]”
Since hypertension is regulated by mechanisms in the SNS[78] which are
ultimately controlled by the CNS we can conclude that fructose[75] causes
lactate elevation this lactate then leads to the CNS transferring across the BBB
[76] into neuronal cells creating excitation and neuronal apoptosis contributing to
the possible onset of hypertension.

2.13 Fructose in the CNS is linked to inflammation
GLUT5 has been shown to be expressed in the CNS, and it has the ability
to transport fructose in microglial cells. The transportation of GLUT5 may have
an effect on glial and neuronal interactions. For example, glial cells can multiply
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when the brain experiences inflammation, in a sense this also occurs when
angiotensin II brings about hypertension [21] and fructose induced hypertension.
A high fructose diet has been linked to inducing hypothalamic proinflammatory
cytokine (PICs) production and astrogliosis, which is the increase in astrocyte
production due to the fate of neighboring neurons becoming traumatized,
infected, or inflamed[22]. According to Jian-Mei Li et. al., fructose induced
astrocytosis inflammation was associated with the TLR4/NF-kB pathway, which
is the main control of hypothalamic inflammatory response and controls the
expression of cytokine genes [80]. Jian-Mei Li et. al. further suggests that
increased histone deacetylase 3 (HDAC3) is associated with fructose induced
inflammation by activation of NF-kB transcription regulator and that the
suppression of HDAC3 overexpression restored fructose neuronal injury[81]. In
addition, the suppression of TLR4/NF-kB pathway also showed restoration from
fructose induced neuronal injury in brain astrocytes [80]. Remarkably, this
demonstrated that theTLR4/NF-kB pathway and HDAC3 are interconnected due
to hypothalamic fructose induced neuronal inflammation [80]. Fascinatingly, NFkB has a primary role in hypertension because NF-KB increased the expression
of pro-inflammatory cytokine (PICs) gene creating inflammation in the PVN which
contributes to hypertension [80]. The connection that inflammation in the brain
occurs and the result is the onset of hypertension is due to a large variety of rat
models, which confirms that abnormal inflammation in the brain contributes to the
rise in mean arterial blood pressure and that respond to the inflamed vasculature
in the brain [25-27]. When rats were intracerebroventricularly (ICV) infused with
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angiotensin II, the brain renin-angiotensin system activated NF-kB in the PVN
which then contributed to an increase in oxidative stress, mean arterial blood
pressure, PICs, aldosterone and norepinephrine [28, 29]. What is unique is that
HDAC3 has the ability to bind to NF-kB inhibitory subunit α which increases
transcription, this resulting in inflammation and then permitted the macrophages
to yield an overwhelming supply of cytokines in the PVN [80, 81].
Brain astrocytes and microglial express GLUT5, the main glucose
transport protein for fructose, and are highly localized in the brain[30]. Astrocytes
in the PVN and superaoptic nucleus (SON) display great anatomical plasticity
and are capable of extensive transformation [82]. Astrocytes also play an
important role in synaptic plasticity and metaplasticity mechanisms [83].
Nevertheless, GLUT5 expression has been particularly linked to synaptic activity
dysfunction due to fructose induced hypertension and high fat plus high fructose
diets [83]. During the 4% high salt chow plus 20% fructose drinking water diet in
SD rats for 3 weeks, GLUT5 expression in the PVN was increased dramatically
compared to control, 4% high salt diet, and 20% fructose alone diet (data not yet
published). When rats were fed a high fat and high fructose diet for 8 months
there was a noticeable reduction in spine density, synaptic plasticity, and low
levels of brain-derived neurotrophic factor (BDNF) [84]. In another study, adult
male SD rats were given a high fructose solution alone and that showed an
impact on synaptic plasticity by utilizing a synaptic growth marker,
synaptophysin, which was measured and found to be decreased during a high
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fructose diet. According to Shi et. al., when fructose induced hypertension
occurred there was an activation of glial cells and an increase in proinflammatory
cytokines in the paraventricular nucleus (PVN) of the brain [85]. The
inflammation from hypertension recruits the glial cells to develop properties
similar to that of macrophages [86]. This includes glial cells which then release
chemical mediators that may be associated between neuron cells and synaptic
strength, density, and size [86]. As stated by Pedro Cisternas et. al., an
observed decrease in postsynaptic density (PSD) from 68 nm to 33 nm was
indicated in fructose-fed groups of mice as well [11].

2.14 Model: fructose and high salt mediates hypertension
It is believed that fructose and salt synergistically have a hypertensive
effects[87]. Fructose stimulates salt absorption in the small intestine specifically
the jejunum, and the kidney [88]. Interestingly, it is thought that GLUT5 is
responsible for enhancing the absorption of fructose and salt in the intestine [27,
87]. Enterocytes lining the villus of the intestine have used GLUT5 as the major
fructose transporter to pass fructose, rapidly, through the apical membrane [26].
GLUT5 wild type mice when given a high fructose diet (60% fructose) for a total
of 14 weeks have increased salt absorption is facilitated through increased
expression of a putative anion transporter 1 (PAT1) and sodium hydrogen
exchanger (NHE3) in their jejuna and kidney tubules. [87]. In addition, Sharon
Barone et. al. then demonstrated that the GLUT5 wild type mice with a high salt
and high fructose diet have developed systemic hypertension compared to the
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GLUT5 knockout mice [27]. Fascinatingly, there is no known research that aims
to find whether the brain synergistically uses fructose and salt combination to
bring about the onset of hypertension. Given this, we live in a day where our
diets include high fructose corn syrup (HFCS) and substantial amounts of salt,
but the molecular effects of the high salt and fructose in the CNS remain in
unclear.

2.15 Review Article Conclusion
These reviewed studies and metabolism of fructose in the body and brain
suggest that fructose plays a large role on the effects of the central nervous
system. We also suggest that fructose effects the CNS, not only by its ability to
generate fructose from glucose, but also that high fructose levels can disrupt glial
and neuronal interactions resulting in consequences. Our future study will
investigate whether or not fructose and salt synergistically mediate hypertension.
We will focus on fructose effects of the CNS and ultimately aim to find fructose’s
contribution to hypertension.
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3 Chapter 3: Methods
3.1 Animal Models, Diets, Blood Pressure, and Metabolic Cages
Male rats were purchased from Charles River Laboratories in Wilminton,
MA. Sprague Dawley (SD) eight-week-old rats were started on a specialized diet
including 1) normal chow (0.4% NaCl, Envigo RMS, IN, USA) with normal
drinking water, 2) high salt chow (4% NaCl, Envigo, RMS, IN, USA) with normal
drinking water, 3) normal chow with 20% D-(-)-fructose (Sigma-Aldrich) drinking
water, and 4) high salt chow with 20% D-(-)-fructose (Sigma-Aldrich) for a total of
3 weeks. The tap water was autoclaved for 15 minutes at 150°C prior to adding
the fructose into it and then stored in a 4°C fridge. Fructose was not autoclaved
in this experiment. Fructose water bottles were changed every 3 days to prevent
mold from growing. Prior to giving SD rats these specialized diets their blood
pressure (baseline) recordings were tested using the methods as described in
the section “blood pressure measurements”. Rats were given free access to
food and water. Rats with fructose water were given a supplemental water bottle
with normal drinking water in it. All rats were housed three rats per cage in a
temperature (22.7 ± 1.0 °C) and humidity (60 ± 10%). When rats were
transferred to the metabolic cages, the rats maintained their specialized diet and
were housed independently. Rats were given 24-hours to acclimate to their
environment and any measurements within the first 24-hours was discarded. A
12-hours light and 12-hour dark cycle was maintained between 0700ET-1859ET
and 1900ET-0659ET, respectively. Experimental operations were completed
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within the Animal Care Facility at Michigan Technological University. All proper
care and procedures of the rats was maintained throughout this study.
Prior to the diet treatment mean arterial blood pressure in conscious SD
male rats were measured by non-invasive tail cuff using CODA© systems from
Kent Scientific Corporation. Measurements for each male rat represents two
separate recordings per week. Prior to the tail cuff recordings and specialized
diets, all rats were acclimated to the animal holders for three consecutive days
for 10 minutes each day. On the day of the recordings, each rat was place in the
animal holder for 10 minutes before each blood pressure reading was recorded.
For each blood pressure recording, the first five of the twenty cycles total were
dismissed from this experiment during each run. After 3 weeks of measuring
blood pressure and weights, rats were placed in the metabolic cages. Each rat
has its own metabolic cage. 24-hours was allowed for the rats to acclimate to the
metabolic cages and then measurements were recorded for the following three
consecutive days. Rats maintained their specialized diet while in the metabolic
cages. On the fourth day, rats were euthanized for brain tissue sampling as
described below.

3.2 Paraformaldehyde infusion and brain sectioning
Eight-week-old male Sprague Dawley (SD) rats were divided into 4 groups
and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS: 4%
NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose (HS+F:
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4% NaCl and 20% fructose water) for 3 consecutive weeks. Adult male SD rats
were euthanized by being injected with pentobarbatol (0.1 ml per 100g of body
weight, 50 mg/kg). When the rats demonstrated a surgical level of anesthesia
via toe pinch-response method, they were transferred into a surgical hood.
Positioning the rat in a supine position, an incision in the integument and
abdomen wall inferior to the rib cage was made. The diaphragm was completely
cut in order to expose the pleural cavity. A continuous cut was made along the
rib cage to the collar bone and repeated on the contralateral side. The sternum
was clamped with the hemostat and placed over the rats head, and additional
tissues connected to the heart was trimmed away to expose the beating heart.
An incision to the right atrium was made and the 22-guage perfusion need was
placed into the left ventricle towards the ascending aorta. After eliminating air
bubbles from the tube, the 4% paraformaldehyde was infused into the rats
system. Fixation tremors were observed within seconds of infusion and the rat
was infused with PFA for a total of 10-15 minutes. The head from the rat was
removed, and the brain was carefully removed from the skull. The brain
remained in 4% paraformaldehyde in -4°C for 24-hours in a test tube and then
was placed in 30% sucrose water for 3-4 days. Brain sections were cut no
longer than 4 days in 30% sucrose using the cryostat machine (Leica
Biosystems©). Brain cross-sections, specifically the paraventricular nucleus
(PVN), were cut at 25µm starting from the optic nerve.
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3.3 Immunostaining
Immunostaining of PVN GLUT5 was performed with the succeeding
procedures: brain coronal sections (25um) containing the PVN was first washed
in PBS for 3 times for 10 minutes total. After washing the slices with PBS, then
the brain cross sections were incubated with 5% horse serum in PBS for 30
minutes. Then the cross sections were incubated with anti-GLUT5-antibody
(Santa Cruze Biotechnology, CA, USA) with a 1:100 dilution in PBS containing
0.5% Triton C-100 and 5% horse serum for 3 days at 4⁰C (trays were wrapped in
parafilm to prevent dehydration). After 3 days, brain cross sections were washed
with PBS 3 times for 10 minutes each. After the washing, the brain sections
were then incubated with secondary antibody donkey Anti-Mouse IgG, Alexa
Fluro® 488 (1:500 dilution) overnight at 4⁰C while covered in aluminum foil to
prevent photo-bleaching. In order to confirm that the observed antibody was
staining, a negative control was performed for each antibody. The negative
control was subjected to identical protocol for consistency similar to that of
regular immunostaining. Instead, the negative control had PBS to ensure there
was non-specific binding to other cellular sections that could possibly fluoresce.
All sections were mounted in Vectashield© medium and glass slides and photos
of each section were taken with Leica© DMIL microscope.

3.4 Fructose Assay
Eight-week-old male Sprague Dawley (SD) rats were divided into 4 groups
and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS: 4%
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NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose (HS+F:
4% NaCl and 20% fructose water) for 3 consecutive weeks. Adult male SD rats
were euthanized, blood serum and CSF was collected from each rat and 20uL of
serum and CSF was used to determine the rat’s true physiological measurement
of fructose within itself after each specialized diet intake. Following the
manufacturer’s instructions data was obtained.

3.5 Real-time PCR (qPCR) Analysis of PVN GLUT5 mRNA
Expression
Eight-week-old male Sprague Dawley (SD) rats were divided into 4 groups
and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS: 4%
NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose (HS+F:
4% NaCl and 20% fructose water) for 3 consecutive weeks. Following the
special diet treatment, rats were euthanized and their brains were removed.
Paraventricular nucleus (PVN) tissue from the hypothalamus was punched.
Punched PVN tissues were exposed to RNA isolation (RNeasy plus mini kit,
Qiagen, CA, USA), and manufacture’s guidelines were followed. qPCR was
used to measure mRNA levels of GLUT5 using a primer or probe from the Real
Time PCR System (Applied Biosystems, CA, USA). All data here was
normalized to the housekeeping gene GAPDH mRNA.

3.6 Ion Chromatography
Eight-week-old male Sprague Dawley (SD) rats were divided into 4 groups
and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS: 4%
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NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose (HS+F:
4% NaCl and 20% fructose water) for 3 consecutive weeks. Rats were then
euthanized and blood, CSF and brains were collected. CSF and Serum samples
were drawn for ion chromatography data. As previously described by Andrew
Chapp 2018 et. al., serum and CSF samples were prepared to be tested in ion
chromatography by adding 10uL of serum or CSF with 9.990 mL of ddH20 (18
MΩ), and then samples were vortexed and filtered from a syringe into sterilized
vials [89]. Blood serum and CSF samples were then run by ion chromatography
to determine their anions and cations [89].

3.7 Neuronal Culture Isolation
Primary neurons cultures were isolated using sterile technique from 24
hour old SD rats. Rat under 24 hours of age were euthanized and their whole
brain was immediately separated apart from the cranium and vigilantly dropped
into sterile DPBS solution. From the whole brain, neuron cells were carefully and
quickly isolated and then plated into poly-L-lysis cultured dishes. It is known that,
neuronal cultures contain mostly primary neuron cells and only about 5%
astroglial cells. Primary neuronal cells medium that was used contained 1%
penicillin and 10% horse serum in Dulbecco’s Modified Eagle Medium© (DMEM).
After two days from neuronal isolation, 50uL of ARC was added to 50mL of fresh
medium, the cytosine arabinoside (ARC) sat in the isolated neuron cells for no
more than 48 hours and then medium was changed back to fresh 1% penicillin
plus 10% horse serum in DMEM (without ARC). Medium was not changed here
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after this point, if needed, no more than 100uL of new medium was added one
week after neuronal isolation. Primary neuron cells were maintained for 10-14
days old to ensure neuron cells had proper dendritic connections with other
neuron cells or the plate.

3.8 Measurement of pro-inflammatory cytokines by Real-Time
PCR in primary neurons cells
Primary neurons cultures were isolated using sterile technique from 24
hour old SD rats as described above. Cultures were made from Sprague Dawley
(SD) rats whole brains containing the PVN. Momentarily, SD rats were
euthanized and then the whole brain was immediately removed and tissues were
combined. Neurons were disconnected with each other and promptly plated in
poly-l-lysine coated dishes. Neuronal cultures contain nearly ~95% of neurons
the remaining ~5% are astroglia cells. On the fourteenth day of neuron cells
being plated in the sterile dish they were then subjected to treatments of fructose,
sodium chloride (NaCl) and a combination of both at different concentrations. A
control (no treatment what-so-ever) was always accounted for in each
experiment.

3.9 Osmolarity
Eight-week-old male Sprague Dawley (SD) rats were divided into 4 groups
and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS: 4%
NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose (HS+F:
4% NaCl and 20% fructose water) for 3 consecutive weeks. Rats were put in
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metabolic cages for 4 nights then immediately after they were euthanized and
blood, CSF and brains were collected. Urine, serum and CSF OSM was
determined by the osmometer machine on the male SD rats for each rat group.
Fresh ddH2O (18Ω) water was used in this osmometer. The machine was
cleaned and standard solutions (290 mmol/kg and 1000 mmol/kg X3 runs) were
used to calibrate the OSM machine prior to running any samples. Urine samples
were diluted 10X in order for the machine to determine the value. CSF and blood
serum were not diluted for determining OSM. (Data of osmolarity will not be
provided for this thesis)

3.9 Data Analysis
Summary data is expressed in standard error of the mean (±SEM). Both in
vitro and in vivo data were analyzed using a one-way Anova or unpaired student
t-test. Evidences against the null hypothesis was considered statistically
significant only if the P-value is < 0.05 indicated with an asterisk (*). A P-value >
0.05 would indicate weak evidence so that data would be considered failure to
reject the null hypothesis.
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4 Chapter 4: Results
4.1 A High Salt plus Fructose Diet Increases Blood Pressure in
SD Rats
In order to prove that a 4% NaCl high salt diet plus 20% fructose water
diet (HS+F) stimulated hypertension in SD rats and not on other specialized
diets; eight-week-old male SD rats with the same ages were placed on either a
NS or HS diet with and without fructose drinking water (NS, HS, F, HS+F) for 3
weeks. Blood pressure was measured via non-invasive tail-cuff
plethysmography twice a week for 3 weeks (Figure 4.1a) and body weight was
measured once per week for 3 weeks (Figure 4.1b). After 3 weeks of diet
treatment the rats were housed independently in metabolic cages. Food and
water intake along with urine and fecal output was measured for 4 consecutive
days (Figure 4.1c). The first day of the metabolic data was discarded since the
change of surroundings causes a rat to stress this day was reserved for
acclimation to the metabolic cages. SD male rats on the NS (control) diet before
the 3 weeks (91 mm Hg) compared to after 3 weeks (89 mm Hg) showed no
statistical difference in mean arterial blood pressure (MAP) which is expected for
control (Figure 4.1a). The SD male HS rat group 3 weeks before the HS chow
treatment (93 mm Hg) showed no significant difference in MAP compared to 3
weeks after the HS diet treatment (96 mm Hg) (Figure 4.1a) . The SD male F rat
group 3 weeks before the 20% fructose drinking water treatment (97 mm Hg) and
after 3 weeks of 20% fructose in drinking water treatment (98 mm Hg) showed no
statistical difference in MAP as well (Figure 4.1a). Surprisingly, the HS+F SD
42

male rat group (HS+F baseline: 98 mm Hg) showed a significant statistical
difference in MAP after the 3 weeks of a HS chow combined with 20% fructose in
drinking water (126 mm Hg) (Figure 4.1a).
In summary, after three weeks of special diets SD rats on a NS diet (89
mm Hg), HS alone diet (96 mm Hg), and F alone diet (98 mm Hg) showed no
change in MAP. However only when the combined diet HS+F (127 mm Hg) was
given there was an increase in MAP. The SD rat group for NS has a significant
(P<0.000001) increase in MAP by a total of ~36 mmHg compared to itself prior to
receiving a special diet treatment (Baseline of NS rats: 91±3 mmHg vs. HS+F
rats after 3 weeks of diet 127±6 mmHg) (Figure 4.1a).

Figure 4.1a Conscious mean arterial blood pressure (MAP) for Sprague Dawley
(SD) rats on a normal salt (NS; 0.4% NaCl and normal water; n=15), high salt
(HS; 4% NaCl and normal water; n=15), fructose (F; normal chow and 20%
fructose water, n=15), and high salt plus fructose (HS+F; 4% NaCl chow plus
20% fructose water, n=15) diet before and after 3 weeks of diet treatment.
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Figure 4.1b Rat’s body weights were measured for each rat given a normal salt
(NS; 0.4% NaCl and normal water, n=5), high salt (HS; 4% NaCl and normal
water n=5), fructose (F; normal chow and 20% fructose water; n=5), and high salt
plus fructose (HS+F; 4% NaCl chow plus 20% fructose water, n=5) diet before
and after 3 weeks of diet treatment.
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Water Inake

Urine Output

Fecal Output

Figure 4.1c After 3 weeks of each rat given a normal salt (NS; 0.4% NaCl and
normal water), high salt (HS; 4% NaCl and normal water), fructose (F; normal
chow and 20% fructose water), and high salt plus fructose (HS+F; 4% NaCl chow
plus 20% fructose water) diet they were subjected to metabolic cages. Rat’s
food and water intake along with urine and fecal output was measured every 24
hours for 4 days. *P<0.05, student paired t test. One Way Anova performed on
urine and water intake P<0.005. (n=15 per each group).

4.2 Immunostaining
To provide results that GLUT5 was demonstrated to be expressed in the
rats PVN brain area and plays a role in whether a HS+F diet alters GLUT
expression in SD rats and age matched those of the NS. Eight-week-old male
SD rats were fed either a NS or HS diet with and without fructose drinking water
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(NS, HS, F, HS+F) for 3 weeks. After 3 weeks, SD male rats were euthanized
and whole brains were taken and immediately frozen in liquid nitrogen. Brain
slices were cut on a cryostat machine at 20µm thick. PVN area were used for
immunostaining with GLUT5. All groups were stained (not shown). HS alone
diet and F alone diet groups of brain GLUT5 immunostaining did not show any
expression, all images were dark so they are not revealed in the following figure.
GLUT5 is highly expressed in the high salt plus fructose treatment of the brain
hypothalamic PVN tissue (Figure 4.2 c,d).
Control 20X

Control 4X

HS+F 20X

HS+F 4X

Figure 4.2 The area of the PVN surrounding the third ventricle (3V) is shown by
4X magnification (a) of the PVN for the NS (control group), and (b) demonstrates
the area in the box at 20X magnification for the NS group. The area of the PVN
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sounding the 3V is shown by 4X magnification (c) for the HS+F group and (d)
shows the area of the box at 20X magnification of the HS+F group.

4.3 Real Time Polymerase Chain Reaction of GLUT5
To further provide evidence that GLUT5 is expressed in the brain
hypothalamic PVN we performed Real Time PCR (qPCR) of the PVN area.
Eight-week-old male SD rats were fed either a NS or HS diet with and without
fructose drinking water (NS, HS, F, HS+F) for 3 weeks and their age matched
that of the previous rats. The SD male rats were euthanized after their special
diet treatment (NS, HS, F, HS+F), PVN tissue was punched out and qPCR was
performed to evaluate the neuronal maker for fructose which was GLUT5 mRNA
levels. SD rats on a NS, HS and F alone diet showed not significant difference in
the change of PVN mRNA levels of GLUT5 (NS: XX, HS: XX, F: XX) compared
to HS+F SD eight-week-old male rats (P<0.05). GLUT5 was confirmed to be
upregulated in the brain hypothalamic PVN tissue for the HS+F rats compared to
the NS, HS, and F rat groups (Figure 4.3).
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Figure 4.3 Real Time PCR (qPCR) data for four different groups: NS (control),
HS (4%NaCl chow, normal drinking water), F (normal chow, 20% fructose
drinking water), HS+F (4%NaCl chow with 20% fructose drinking water),
respectively. GLUT5 is upregulated in HS+F group. (NS: n=5, HS: n=3, F: n=2,
HS+F: n=4)

4.4 Fructose Assay
To determine the physiological concentration of fructose from in vivo of the
rat’s blood serum and CSF fructose assay kit was utilized. This was done to
ensure similar concentrations were used for in vitro studies. Eight-week-old male
SD rats were fed either a NS or HS diet with and without fructose drinking water
(NS, HS, F, HS+F) for 3 weeks and their age matched that of the previous rats.
The SD male rats were euthanized after their special diet treatment (NS, HS, F,
HS+F), and blood serum, CSF and whole brains were collected. Manufactures
instructions were followed for the fructose assay kit. Fructose concentrations in
blood serum increased to 359µM in the fructose group, and to 409µM in the
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HS+F group (P<0.05) compared to NS group of 253µM (Figure 4.4a). CSF
fructose decreased in the F group to 230µM (P<0.05) compared to the NS group
of 290uM (Figure 4.4b).

Figure 4.4a Blood serum of 8-week-old Sprague Dawley (SD) rats were
withdrawn from four different groups: NS (control), HS (4%NaCl chow, normal
drinking water), F (normal chow, 20% fructose drinking water), HS+F (4%NaCl
chow with 20% fructose drinking water), respectively. Serum concentration
increased in the F and HS+F group. (NS: n=5, HS: n=3, F: n=4, HS+F: n=5).
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Figure 4.4b CSF of 8-week-old Sprague Dawley (SD) rats were withdrawn from
four different groups: NS (control), HS (4%NaCl chow, normal drinking water), F
(normal chow, 20% fructose drinking water), HS+F (4%NaCl chow with 20%
fructose drinking water), respectively . CSF fructose decreased in the F group
compared to the NS group. (NS: n=5, HS: n=3, F: n=4, HS+F: n=5).

4.5 Ion Chromatography
To determine the anions and cations of the SD male rat’s CSF, ion
chromatography was utilized for this purpose. After 3 weeks of each SD male rat
given a normal salt (NS; 0.4% NaCl and normal water), high salt (HS; 4% NaCl
and normal water), fructose (F; normal chow and 20% fructose water), and high
salt plus fructose (HS+F; 4% NaCl chow plus 20% fructose water) diet their CSF
sodium, acetate, lactate, magnesium, potassium, and calcium was measured
(Table 1). A significant difference water determined (P<0.05) between sodium
and the control/NS group (150.47 mM) vs. the HS+F (160.6 mM) group (Figure
4.5a) and there was also a statistically significant difference (P<0.05) regarding
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acetate levels in the CSF between control (0.0715 mM) vs. F (0.1007 mM) and
control (0.0715 mM) vs. HS+F (0.1945 mM) groups (Table 1).
Averaged CSF Electrolytes for Eight-Week-Old Male SD Rats After 3
Weeks of A Special Diet Treatment Give

Cations

Anions

Diet
Group

Calcium
(mM)

Potassi
um
(mM)

Sodium
(mM)

Magne
sium
(mM)

Acetate
(mM)

Lactate
(mM)

Chloride
(mM)

NS

3.1

2.5

150.5

2.1

0.0715

2.6

119.3

HS

3.5

2.3

158.1

2.2

0.1551

2.5

124.3

F

3.4

2.1

155.1

1.9

*0.1007

2.1

120.9

HS+F

2.9

2.1

*160.6

2.1

*0.2

2.8

125.1

Table 1 Eight-week-old male Sprague Dawley (SD) rats were divided into 4
groups and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS:
4% NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose
(HS+F: 4% NaCl and 20% fructose water) for 3 consecutive weeks. Rats were
euthanized and CSF was withdrawn from the rats. CSF was tested for calcium,
potassium, sodium, magnesium, acetate, lactate, and chloride. *P<0.05
compared to the control (NS) group. (n=5 per each group).
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*

Figure 4.5a Eight-week-old male Sprague Dawley (SD) rats were divided into 4
groups and were fed a normal salt chow (NS: 0.4% NaCl), high salt chow (HS:
4% NaCl), NS with fructose (F: 20% fructose water), and HS plus fructose
(HS+F: 4% NaCl and 20% fructose water) for 3 consecutive weeks. Rats were
euthanized and CSF was withdrawn from the rats. Sodium in cerebrospinal fluid
(CSF) was obtained by ion chromatography. Control (NS): 150.4739 mM; HS:
158.0899 mM; F: 155.1233 mM; HS+F: 160.6339 mM. *P<0.05 compared to the
control (NS) group. (n=5 per each group).

4.6 Real Time PCR for Pro-inflammatory Cytokines of Brain
Neurons
In order to determine the inflammatory responsible for inducing pre-inflammatory
cytokines during a high salt and fructose treatment, primary neuronal cultures
from the whole brain of less than 24-hour old SD male rats were incubated with
high salt, fructose, and a combination of high salt and fructose treatment for 6
hours. Real time PCR was performed to measure mRNA levels of NfKB1
(Figure 4.6a) and IL6 (Figure 4.6b).
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Figure 4.6a Primary neuron cells were isolated from SD rats within 24 hours of
birth. 12-day-old neurons were treated with different doses of salt and fructose
for 6 hours and then RNA was extracted and then converted to cDNA followed by
RT PCR. HS represents 5mM of NaCl treatment, F indicated 5mM of fructose
and HS+F indicates 5mM of high salt combined with 5 mM of fructose.

Figure 4.6b Primary neuron cells were isolated from SD rats within 24 hours of
birth. 12-day-old neurons were treated with different doses of salt and fructose
for 6 hours and then RNA was extracted and then converted to cDNA followed by
RT PCR. HS represents 5mM of NaCl treatment, F indicated 5mM of fructose
and HS+F indicates 5mM of high salt combined with 5 mM of fructose.
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4.7 Flow Cytometry of Primary Neuron Cells
Isolated primary rat neuronal cells demonstrated apoptosis as a reaction
to fructose and/or sodium chloride (NaCl) treatments. Incubation of brain neurons
isolated from neonatal SD rats with 200µM (17.2%, P<0.05) and 1mM (22.5%,
P<0.005) of a 6 hour fructose treatment stimulated neuronal apoptosis (Figure
4.+-7) compared to the control (14.1%). Isolated neurons were also subjected to
a 6 hour treatment of NaCl alone (19.1%, no significant difference), and a
combination of 200µM fructose + 5mM NaCl (22.3%, P<0.005) (Figure 4.7).
Finally, we tested 1mM of fructose + 5mM NaCl (24.3%, P<0.005) on primary rat
neuronal cells (Figure 4.7). This study demonstrated that HS+F diet decreases
CSF fructose concentration, and that the physiological amount of fructose
concentration is shown to stimulate neuronal apoptosis in brain neurons, and
increases PVN GLUT5 expression, which may result in hypertension.
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Flow Cytometry Data from Primary Isolated Neuron Cells Treated
with Either NaCl, Fructose and Both
(a)

(b)

(c)

(d)
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(e)

(f)
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(g)

Figure 4.7 Primary neuron cells were isolated from SD rats within 24 hours of
birth. 12-day-old neurons were treated with different doses of fructose for 6
hours and then stained with propidium iodine (PI) and flow cytometry was
performed. (a) Represents the control group, (b) is the 5mM of NaCl treated
neuron cells for 6 hours. (c) is the 200µM fructose treated neurons for 6 hours,
and (d) is 1mM of fructose treatment for 6 hours. (e) Represents the
combination of 6 hour treatments 200µM Fructose+5mM NaCl and (f) is the
combined 6 hour treatment of 1mM fructose+5mM NaCl. (g) Is the percentages
of neuronal apoptosis of from each treatment depicted in (a-f). *P<0.05,
#P<0.005. (n=4 per each group).
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5 Chapter 5: Discussion
5.1 Main Idea
The central nervous system (CNS) plays an imperative role in blood pressure
regulation and has been thought to be the primary role of fructose-induced
hypertension. The sympathetic nervous system (SNS) plays a more important
role in controlling blood pressure (BP). More specifically, the pre-sympathetic
neurons with efferent projections to the brainstem areas are the central regulator
of the SNS. The pre-sympathetic neurons contribute to the main role in blood
pressure regulation and sympathetic nervous system activity (SNA). However,
the key area that has control of BP and SNA is the paraventricular nucleus of the
hypothalamus (PVN). The PVN includes monosynaptic, and glutamatergic
projections to the rostral ventrolateral medulla (RVLM) which impacts
sympathoexcitation.
Taking everything into consideration evidence suggests that a high salt and
fructose diet alters neuronal cells by stimulating neuronal apoptosis and fructose
stimulates salt uptake in brain CSF resulting in upregulation of GLUT5 in brain
paraventricular nucleus (PVN) of the hypothalamus. Since the PVN is a key presympathetic region with regulatory control over BP and SNA then we have shown
here that the high salt and fructose diet combined is the main contributor to BP
regulation and responsible for the increase in BP.
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Evidence that the PVN tissue expressed GLUT5 demonstrates that a combined
high salt and fructose diet may play a more central role in of cardiovascular
function contributing to hyperactivity in the PVN area resulting to neurogenic
hypertension[90]. The mechanism of fructose induced hypertension is not
known. This study is also the first to determine that elevated sodium levels is
seen in a SD male rats after three weeks of diet treatment of 4% NaCl combined
with 20% fructose drinking water (HS+F) relative to the control; NS, normal salt
plus normal drinking water.
First, MAP is increased by a total of 37 mmHg in eight-week-old SD male rats
after just 3 weeks of a HS+F diet compared to NS rats. Second, the expression
of GLUT5, a fructose transporter, is expressed in brain PVN and quantified by
real time PCR demonstrated upregulation of GLUT5 in PVN tissue. Third, brain
hypothalamic primary neurons exposed to fructose plus sodium uptake in brain
neurons results in apoptosis in just 6 hours of treatment. Finally, CSF sodium
was increased is those rats who were given a 20% fructose diet and even a
higher increase in sodium from the rats who received HS+F diet treatment.
Although, CSF fructose concentrations of the HS+F rats decreased compared to
control may be an indication that a moderate fructose consumption alone may
stimulate sodium uptake in CSF of adult Sprague Dawley (SD) male rats. What
is interesting is that Per Enshe Jiang et. al. 2018, confirmed that CSF sodium
concentrations of Dahl salt sensitive rats was elevated when given a HS 4%
NaCl diet (158 mM) [91] compared to this study when SD rats when fed a HS+F
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diet (160 mM). As you can see the CSF sodium concentrations of the Dahl salt
sensitive rats compares to the HS+F SD rats. This further indicates that the
combined high salt and fructose diet stimulates salt sensitivity linking to an
increase in mean arterial blood pressure through means of the PVN. Since the
PVN includes the monosynaptic and glutamatergic projections to the rostral
ventrolateral medulla (RVLM) which impacts sympathoexcitation. Simply put,
this combined high salt and fructose diet creates the abnormalities of the central
regulation of SNA which dysregulates the pre-sympathetic neurons.
Furthermore, we have sought here that salt changes the GLUT5 protein
transporter in the PVN under a high salt and fructose combined diet. The
changes made in the GLUT5 protein transporter may be the contribution to
inflammation and neuronal apoptosis further linking to hypertension.
Collectively, our results demonstrated that fructose may cause hypertension
through the mechanism of neuronal apoptosis in the PVN and that a HS+F diet
contributes to salt sensitivity in SD rats. The PVN, protected by the blood brain
barrier, is the main site for neuroendocrine and automatic function [92, 93].
Expression of GLUT5 after high salt and fructose diet is unknown to be
widespread in the entire body, but the PVN area demonstrated GLUT5
expression which may be the missing link when contribute to blood pressure
regulation during fructose-induced hypertension.
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5.2 Summary
Here we have demonstrated that fructose and salt synergistically create
hypertension in eight-week-old male Sprague Dawley (SD) rats. Furthermore,
we have demonstrated that an increased expression of GLUT5 in the PVN of SD
rats who were given a 4% high salt and 20% fructose drinking water (HS+F) diet
for 3 weeks. This suggests that a HS+F diet stimulates the uptake of fructose
into neuronal cells which results in the increase of intracellular fructose and an
increase in CSF sodium concentrations. The increase in CSF sodium
concentrations is comparable to Dahl salt sensitive rats on a high salt diet [91].
The upregulation of nuclear factor NS-kappa B (NFkB1) in the PVN of the HS+F
rats further demonstrates that a fructose and high salt diet is linked to
inflammation and inappropriate immune cell damage in the CNS.
To review the data, this study demonstrated that a just 3 weeks of a HS+F
diet increased MAP in SD male adult rats. Chow (food) intake decreased in F
and HS+F SD rat groups. Water intake and urine output increased significantly
in HS and H+F rat groups only which is hallmark for diagnosing hypertension.
Rat’s fructose concentration increased in serum in F and HS+F but decreased in
CSF for F and HS+F SD male rat. HS+F SD male rat group increased GLUT5
expression in the brain hypothalamus and in the PVN area. Increased mRNA
expression of GLUT5 in the PVN area was demonstrated by real time PCR
compared to NS, HS, and F groups. CSF sodium increased in HS+F group
which is comparable to Dahl salt sensitive rats on a high salt diet.
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5.3 Outlooks
This research sheds light on the gap in knowledge between the connection
of fructose and salt intake and hypertensions within the CNS. Those with
hypertension or pre-hypertension and metabolic syndrome are at risk for stroke,
cardiovascular disease, and heart failure. Increase salt and fructose combined
intake contributes to both hypertension especially in metabolic syndrome
patients. It is of great interest for those with pre-hypertension to decrease intake
of fructose and salt consumption. For further treatment and to reduce the
number of cardiovascular deaths the salt sensitive population should watch both
salt and fructose intake. This study indicates that a combined salt and fructose
diet increase CSF acetate and mediates hypertension through neuronal
apoptosis and increasing pro-inflammatory cytokines.

5.4 Future Studies and Restrictions
Brain PVN punch tissue is not exact, and obtaining a portion of the other
brain areas may occur. The blood pressure tail cuff method was used, but to
better this study the renal transducers should be implanted in the rats to
determine a more accurate blood pressure recording. Other future studies
include an interperotoneal injection of fructose to determine a more acute
increase of lactate response in the cerebral spinal fluid (CSF) by measurements
done from ion chromatography.
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6 Chapter 6: Supplementary Tables and Diagrams
6.1 Animal Model Timeline for Diet Treatments and Metabolic
Cage Measurements
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6.2 Blood Pressure Apparatus
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6.3 Primary Cultured Neuron Cells for RT PCR and Flow
Cytometry

(#) represents the concentration used for flow cytometry; (*) represents the
concentrations used for real time PCR
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6.4 Immunostaining Flow Diagram
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6.5 Co-Immunostaining Brain Section Pictures
Control X4

Control X20

HS 4X

HS 20X

Fructose 4X

Fructose 20X
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HS+F 4X

HS+F 20X
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